Alerus Financial’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$112K Hold
200
0.01% 263
2025
Q4
$135K Hold
200
0.01% 187
2025
Q3
$128K Hold
200
0.01% 204
2025
Q2
$107K Buy
+200
New +$95.6K 0.01% 190
2022
Q2
Sell
-468
Closed -$256K 177
2022
Q1
$256K Sell
468
-1,826
-80% -$961K 0.02% 166
2021
Q4
$1.51M Buy
2,294
+1,826
+390% +$1.15M 0.12% 128
2021
Q3
$291K Hold
468
0.03% 166
2021
Q2
$296K Hold
468
0.03% 173
2021
Q1
$229K Hold
468
0.02% 177
2020
Q4
$234K Buy
+468
New +$209K 0.02% 182

Other funds holding IDXX

Alerus Financial's IDXX Position: Q1 2026 in Review

Alerus Financial held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 200 shares worth $112K. The position accounts for 0.01% of the portfolio, ranked #263.

Alerus Financial first reported a position in IDXX in Q4 2020 and has held it in 10 quarters since. The position peaked at $1.51M in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Alerus Financial held 200 shares of Idexx Laboratories worth $112K as of Q1 2026.
  • Alerus Financial left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up 0.01% of Alerus Financial's portfolio in Q1 2026, its #263 holding.
  • Alerus Financial first reported a position in Idexx Laboratories in Q4 2020 and has held it in 10 quarters since.
  • Alerus Financial's Idexx Laboratories position peaked at $1.51M in Q4 2021.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Alerus Financial's 13F filing for Q1 2026, filed 12 May 2026.